Organigram Holdings Inc. OGI OGI and Canndoc Ltd., a subsidiary of InterCure Ltd. INCR INCR INCR have entered into a new multi-year agreement for Organigram to continue supply of dried flower to InterCure.
Organigram and InterCure entered into a previous strategic supply agreement in June 2020, that contemplated a minimum supply of 3,000 kg all of which has been fulfilled. The new strategic agreement contemplates up to 20,000 kg to be supplied to InterCure's international supply chain. Specifically, the new strategic agreement provides for a commitment of 10,000kg with an option for Canndoc to elect to order up to an additional 10,000kg from Organigram during the three-year term. Approximately 2,800 kg has already been delivered to Canndoc from Organigram since July 2022 and credited against the total volume commitment under the new strategic agreement.
Based on the success of the first strategic agreement and the desire of the parties to continue to collaborate and grow their businesses, the new strategic agreement was entered into. Subject to the terms and conditions of the new strategic agreement, Organigram has agreed to exclusively supply InterCure in Israel for the term. Additionally, the parties agreed on certain popular genetics which will be exclusively supplied for distribution into InterCure's international supply chain, subject to local regulations.
“Our business with InterCure a leader in pharmaceutical grade cannabis, has been mutually beneficial and we are excited to expand the relationship going forward,” stated Beena Goldenberg, CEO of Organigram. “This new strategic agreement envisions a significantly greater amount of dried flower to be shipped from Organigram to Canndoc and allows us to collaborate in the future on other emerging medical cannabis markets in European jurisdictions."
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Photo: Benzinga; Sources: courtesy of jarmoluk and lindsayfox via Pixabay
Related News
Israeli Cannabis Producer Touts Record Q3 Revenue, Gross Profit Increase
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!